Hypermanganesaemia with dystonia polycythemia and cirrhosis

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hypermanganesaemia with dystonia, polycythemia, and cirrhosis (HMDPC) is a rare genetic and autosomal recessive disorder that occurs due to mutation of the SLC3A10 gene, which encodes the manganese (Mn) transporter in the body; as a result, Mn accumulates in the brain, liver and muscles. This accumulation leads to symptoms of generalized dystonia, polycythemia, and hypermanganesaemia. In this report, we present the case of a 2½-year-old baby girl (patient) with complaints of lower limb weakness and increased difficulty in walking for six months. Her laboratory test results showed deranged values with increased Mn levels in the body. The patient was put on six cycles of EDTA therapy, which showed an improvement in her condition. This case report is presented to create awareness about a rare genetic disorder with an effective treatment in some cases. Thus, more work and research is required to understand and develop better treatment options for this disease.

Cite

CITATION STYLE

APA

Chand, P., Padhani, Z. A., Akbar, R., & Arain, F. (2022). Hypermanganesaemia with dystonia polycythemia and cirrhosis. Journal of the Pakistan Medical Association, 72(10), 2097–2100. https://doi.org/10.47391/JPMA.1776

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free